aspree
You Will Find The “aspree” Top Links Here. You Have To Click On The Link And Login Into The Account Using The Correct Login Details.
Aspree USA | Studying the effect of Aspirin on healthy …
ASPREE-XT (eXTension) is a follow up study in ASPREE participants to determine whether those in the aspirin group, compared to the placebo group, have different health outcomes such as for cancer, dementia, frailty and other conditions of ageing, over the longer term. The longer term effect of aspirin on health needs to be studied further …
Effect of Aspirin on All-Cause Mortality in the Healthy …
https://www.nejm.org/doi/full/10.1056/NEJMoa1803955
The Aspirin in Reducing Events in the Elderly (ASPREE) trial was a primary prevention trial that was established to investigate whether the daily use of 100 mg of enteric-coated aspirin would …
Aspirin in Reducing Events in the Elderly (ASPREE)
https://www.alzheimers.gov/clinical-trials/aspirin-reducing-events-elderly-aspree
The ASPREE study will examine whether the potential benefits of low-dose aspirin (particularly preventing heart disease, stroke, certain cancers, and dementia) outweigh the risks (particularly bleeding) in people over age 70. ASPREE will determine whether taking a daily low-dose aspirin will extend the length of a disability-free life in …
ASPREE – Wiki Journal Club
https://www.wikijournalclub.org/wiki/ASPREE
The Aspirin in Reducing Events in the Elderly (ASPREE; 2018) trial enrolled 19,114 healthy elderly patients (≥70 years old, ≥65 years old in Hispanic or Black patients) without a history of CVD, cerebrovascular disease, dementia, or any other chronic condition that would likely limit survival to less than 5 years.
Aspirin and Cancer in Older People – National Cancer Institute
https://www.cancer.gov/news-events/cancer-currents-blog/2020/aspree-aspirin-increases…
ASPREE began enrolling participants in 2010 and continued doing so until 2014. Participants were randomly assigned to take either aspirin or a placebo until the trial ended, and most had not taken aspirin regularly before entering the trial.
Monash University – ASPREE – Login page
ASPREE National Co-ordinating Centre Level 5, The Alfred Centre 99 Commercial Road Melbourne VIC 3004 Email support@aspree.freshdesk.com Tel 1800 728 745 Project Manager Brenda Kirpach The Berman Center for Clinical Research …
Aspirin in Reducing Events in the Elderly (ASPREE)
https://clinicaltrials.gov/ct2/show/NCT01038583
ASPREE (ASPirin in Reducing Events in the Elderly) is a joint US/Australian research project aiming to determine whether low-dose aspirin increases healthy life-span, defined as survival free of dementia and disability. ASPREE began in 2010 and completed recruitment in 2014. It is a randomized, double-blind, placebo-controlled, primary …
Aspirin in Reducing Events in the Elderly – ASPREE
https://www.acc.org/latest-in-cardiology/clinical-trials/2018/09/16/21/55/aspree
The ASPREE trial showed that aspirin did not prevent disability-free survival, but did increase major bleeding compared with placebo. Description: The goal of the trial was to evaluate low-dose aspirin compared with placebo among healthy elderly patients.
Effect of Aspirin on Cardiovascular Events and Bleeding in …
https://www.nejm.org/doi/10.1056/NEJMoa1805819
The ASPREE trial showed that, among elderly participants, the use of low-dose aspirin did not result in a significantly lower rate of the primary end point of disability-free survival (a composite …
Aspirin may accelerate progression of advanced cancers in …
https://medicalxpress.com/news/2020-08-aspirin-advanced-cancers-older-adults.html
To provide insights, investigators designed and initiated the ASPirin in Reducing Events in the Elderly (ASPREE) trial, the first randomized double-blind placebo-controlled trial of daily low-d
Conclusion:
This Is How You Can Easily Access The “aspree”. And Use The Features That aspree Offers On Their Portal. If You Have Issues With Login And Other Do Let Us Know In The Comment Section.